Pieris Pharmaceuticals
Biotechnology ResearchView the employees at
Pieris Pharmaceuticals-
Matthias Hagner Early stage Project Lead / Senior Scientist Biology Lead Respiratory bei Pieris Pharmaceuticals
-
Top 5%
Katharina Heinzelmann Senior Scientist & Biology Lead at Pieris Pharmaceuticals GmbH-
Rising Star
Kristina Heinig Team Leader Flow Cytometry and Imaging-
Munich, Bavaria, Germany
-
Rising Star
Sven Berger Antibody delevopment and CMC-
Oslo, Oslo, Norway
-
Rising Star
Shankar Giridhar Vijayakumar Data Science & Digitalization | Business Analysis | Pharmaceutical R&D-
Munich, Bavaria, Germany
-
Rising Star
Overview
Pieris Pharmaceuticals (NASDAQ: PIRS) is a clinical stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way. Our pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the clinic and by partnerships with leading pharmaceutical companies. Pieris is listed on the NASDAQ and trades under the ticker symbol PIRS. Pieris is currently hiring in Boston and Hallbergmoos, Germany. Here you will find the list of our job openings and information on how to apply: https://www.pieris.com/careers
-